Symptomatic non-obstructive hypertrophic cardiomyopathy (nHCM) research hub

A trial to evaluate the safety and efficacy of treatment with azacitidine in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

This study looks at a new drug, azacitidine, for non-obstructive hypertrophic cardiomyopathy (nHCM), a common heart condition. It aims to see if azacitidine is safe and effective in treating nHCM, which currently has limited direct treatments.